(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Holiday Inn London - Regent's Park

Feb 01, 2016 8:00 AM - Feb 05, 2016 1:00 PM

Carburton Street , London, W1W 5EE, United Kingdom

Joint MHRA/DIA Excellence in Pharmacovigilance

This course is designed to provide a firm grounding in key aspects of European Clinical Pre- and Post-Marketing Safety regulatory requirements.

Back to Agenda

TOPIC 2 SESSION 5: Expedited Reporting Requirements in the Post-authorisation Phase and Case Studies

Session Chair(s)

Gaby L. Danan, MD, PhD

Gaby L. Danan, MD, PhD

Pharmacovigilance Expert

GLD, France

Phil Tregunno

Phil Tregunno

Deputy Director - Patient Safety Monitoring

Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

Speaker(s)

Gaby L. Danan, MD, PhD

Expedited Reporting Requirements in the Post-authorisation Phase and Case Studies

Gaby L. Danan, MD, PhD

GLD, France

Pharmacovigilance Expert

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.